Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival

H. van Cruijsen; A.A.M. van der Veldt; L. Vroling; D. Oosterhoff; H.J. Broxterman; R.J. Scheper; G. Giaccone; J.B. Haanen; A.J.M. van den Eertwegh; E. Boven; K. Hoekman; T.D. de Gruijl

doi:10.1158/1078-0432.CCR-08-0656

Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival

H. van Cruijsen
, A.A.M. van der Veldt
, L. Vroling
, D. Oosterhoff
, H.J. Broxterman
, R.J. Scheper
, G. Giaccone
, J.B. Haanen
, A.J.M. van den Eertwegh
, E. Boven
, K. Hoekman
, T.D. de Gruijl

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	5884-5892
Journal	Clinical cancer research
Volume	14
Issue number	18
DOIs	https://doi.org/10.1158/1078-0432.CCR-08-0656
Publication status	Published - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1158/1078-0432.CCR-08-0656

Cite this

van Cruijsen, H., van der Veldt, A. A. M., Vroling, L., Oosterhoff, D., Broxterman, H. J., Scheper, R. J., Giaccone, G., Haanen, J. B., van den Eertwegh, A. J. M., Boven, E., Hoekman, K., & de Gruijl, T. D. (2008). Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival. Clinical cancer research, 14(18), 5884-5892. https://doi.org/10.1158/1078-0432.CCR-08-0656

@article{61bd4ccabc934cd8a41047622862e37d,

title = "Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival",

author = "\{van Cruijsen\}, H. and \{van der Veldt\}, A.A.M. and L. Vroling and D. Oosterhoff and H.J. Broxterman and R.J. Scheper and G. Giaccone and J.B. Haanen and \{van den Eertwegh\}, A.J.M. and E. Boven and K. Hoekman and \{de Gruijl\}, T.D.",

year = "2008",

doi = "10.1158/1078-0432.CCR-08-0656",

language = "Undefined/Unknown",

volume = "14",

pages = "5884--5892",

journal = "Clinical cancer research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "18",

}

van Cruijsen, H, van der Veldt, AAM, Vroling, L, Oosterhoff, D, Broxterman, HJ, Scheper, RJ, Giaccone, G, Haanen, JB, van den Eertwegh, AJM , Boven, E, Hoekman, K & de Gruijl, TD 2008, 'Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival', Clinical cancer research, vol. 14, no. 18, pp. 5884-5892. https://doi.org/10.1158/1078-0432.CCR-08-0656

TY - JOUR

T1 - Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival

AU - van Cruijsen, H.

AU - van der Veldt, A.A.M.

AU - Vroling, L.

AU - Oosterhoff, D.

AU - Broxterman, H.J.

AU - Scheper, R.J.

AU - Giaccone, G.

AU - Haanen, J.B.

AU - van den Eertwegh, A.J.M.

AU - Boven, E.

AU - Hoekman, K.

AU - de Gruijl, T.D.

PY - 2008

Y1 - 2008

U2 - 10.1158/1078-0432.CCR-08-0656

DO - 10.1158/1078-0432.CCR-08-0656

M3 - Article

C2 - 18794101

SN - 1078-0432

VL - 14

SP - 5884

EP - 5892

JO - Clinical cancer research

JF - Clinical cancer research

IS - 18

ER -